Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 5
Submit an article Journal homepage
2,451
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Bacterial ghosts as adjuvant to oxaliplatin chemotherapy in colorectal carcinomatosis

Diana GrozaInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaORCID Iconhttp://orcid.org/0000-0001-6499-3759View further author information
ORCID Icon,
Sebastian GehrigLaboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, AustriaView further author information
,
Pavol KudelaBIRD-C GmbH & CoKG, Vienna, AustriaView further author information
,
Martin HolcmannInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Christine PirkerInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Carina DinhofInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Hemma H. SchuefflInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaView further author information
,
Marek SramkoBIRD-C GmbH & CoKG, Vienna, AustriaORCID Iconhttp://orcid.org/0000-0003-1140-6674View further author information
ORCID Icon,
Julia HoebartLaboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, AustriaORCID Iconhttp://orcid.org/0000-0003-1750-1680View further author information
ORCID Icon,
Fatih AliogluLaboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, AustriaView further author information
,
Michael GruschInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaORCID Iconhttp://orcid.org/0000-0001-5486-9340View further author information
ORCID Icon,
Manfred OgrisLaboratory of MacroMolecular Cancer Therapeutics ( MMCT), Center of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Vienna, Vienna, AustriaView further author information
,
Werner LubitzBIRD-C GmbH & CoKG, Vienna, AustriaView further author information
,
Bernhard K. KepplerInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaView further author information
,
Irena Pashkunova-MarticInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, AustriaView further author information
,
Christian R. KowolInstitute of Inorganic Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaView further author information
,
Maria SibiliaInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, AustriaView further author information
,
Walter BergerInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaCorrespondence[email protected]
View further author information
&
Petra HeffeterInstitute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria;Research Cluster “Translational Cancer Therapy Research”, University of Vienna and Medical University of Vienna, AustriaCorrespondence[email protected]
View further author information
 show all
Article: e1424676 | Received 04 Dec 2017, Accepted 29 Dec 2017, Published online: 16 Feb 2018

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.